Latest news with #Valcreate
Economic Times
2 days ago
- Business
- Economic Times
From Paytm to Eternal: 42 stocks where India's top performing PMS fund managers are betting on
India's top-performing PMS funds placed bold bets in July across 42 stocks, spanning fintech giants, healthcare disruptors, agrochemicals, and industrial leaders. With strategies focused on digital disruption, speciality chemicals, and consumption growth, money managers are positioning portfolios for India's next phase of growth. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Valcreate's Digital Disruption Strategy: Betting Big on Fintech Giants Valcreate's Lifesciences Portfolio: Riding the Agrochemicals Wave Green Portfolio's MNC Advantage: Industrial Excellence Focus Emkay's Pearls Strategy: Diversified Mid-Cap Play Tired of too many ads? Remove Ads Ambit's Micro Marvels: Small-Cap Specialisation Wryght Research Factor Fund: Contrarian Fintech Bet Valcreate's Growing India: Chemical Sector Concentration Shade Capital Value Fund: Value Hunting Across Caps Brightseeds Xylem Maverick: Cash-Heavy Cautious Approach India's sharpest money managers are placing bold bets on the market's most exciting new-age darlings and forgotten gems. The country's top 10 performing Portfolio Management Services (PMS) scheme in July made concentrated plays on everything from fintech unicorns to healthcare disruptors and speciality chemicals, shows data from PMS Bazaar. Here's where the smart money is Asset Management - Healthcare Portfolio: Leading the Pack with 11.96% ReturnsThe month's standout performer, InCred's Healthcare Portfolio, is doubling down on India's medical revolution with a 19.81% allocation to Healthcare Global Enterprises, the country's largest cancer care network. The fund's conviction play extends to diagnostics powerhouse Thyrocare Technologies (17.35%) and emerging player Krsnaa Diagnostics (11.62%).The healthcare-focused strategy also holds Jubilant Pharmova (10.04%) and RPG Life Sciences (6.81%), positioning itself to capitalise on India's growing healthcare infrastructure and rising medical Investment Managers' IME Digital Disruption fund (up 6.34%) is making audacious bets on India's digital economy transformation. The fund has loaded up 22% in Eternal, followed by massive positions in fintech heavyweight One 97 Communications - Paytm (19.30%) and insurance aggregator PB Fintech (19.20%).The digital thesis extends to FSN E-Commerce Ventures - Nykaa (11.40%) and food delivery giant Swiggy (7.10%), capturing the entire new-age commerce ecosystem that's reshaping Indian consumer Valcreate strategy making waves is their Lifesciences and Specialty Opportunities fund (8.48% returns), which has positioned itself as the go-to agrochemicals play. Leading the charge is Sharda Cropchem , with a commanding 15.85% weight, backed by pharma giant Divi's Laboratories (9.33%).The fund's agrochemical conviction deepens with Sumitomo Chemical India (8.08%), Dhanuka Agritech (7.49%), and Rallis India (7.31%), betting on India's agricultural modernisation and crop protection Portfolio's MNC Advantage fund (6.89% returns) is zeroing in on India's industrial backbone through multinational subsidiaries. KSB leads the portfolio at 12.68%, followed by engineering specialist Integra Engineering India (10.21%) and auto components player Federal-Mogul Goetze (9.42%).The strategy includes John Cockerill India (6.16%) and premium engineering brand Bosch (5.56%), capitalising on India's manufacturing renaissance and infrastructure Investment Managers' Pearls fund (4.20% returns) mirrors the digital disruption theme with Eternal as its top holding (16.30%), while maintaining pharmaceutical exposure through Divi's Laboratories (9.70%). The fund balances growth with stability through Nesco (8.80%), Federal Bank (7.10%), and auto ancillary Sundram Fasteners (7.10%).Ambit Investment Advisors' Micro Marvels Portfolio (4.27% returns) is hunting for tomorrow's champions in India's small-cap universe. The fund spreads its bets across Rajratan Global Wire (7.00%), staffing services leader Teamlease Services (6.50%), and industrial plays Menon Bearings, Entero Healthcare Solutions, and Thejo Engineering (6.00% each).The Factor Fund from Wryght Research (2.69% returns) demonstrates conviction in fintech recovery with One 97 Communications as its largest holding (7.73%). The fund diversifies across Hitachi Energy India (5.68%), Maharashtra Scooters (5.38%), fertiliser player Paradeep Phosphates (5.19%), and financial conglomerate Bajaj Holdings & Investment (4.91%).The Growing India fund (2.84% returns) maintains Valcreate's chemical sector thesis with Divi's Laboratories leading at 7.65%, supported by Sharda Cropchem (7.48%) and Rallis India (6.54%). The fund also holds Swaraj Engines (6.32%) and Sumitomo Chemical India (5.82%).Shade Capital's Value Fund (2.87% returns) is pursuing deep value opportunities across industrial names like Kilburn Engineering (4.33%), TD Power Systems (4.15%), and wealth manager Nuvama Wealth Management (3.94%). The fund also holds infrastructure play Transrail Lighting (3.71%) and building materials company Interarch Building Products (3.36%).The most conservative among the top performers, Brightseeds' Xylem Maverick Strategy (2.55% returns) holds a massive 47.29% in Zerodha Nifty 1D Rate Liquid ETF & Cash, suggesting a defensive stance. When invested, the fund focuses on agrochemicals through Dharmaj Crop Guard (8.56%), Sudarshan Chemical Industries (7.00%), renewable energy via Borosil Renewables (6.37%), and steel tubes specialist Scoda Tubes (5.49%).The positioning of India's top PMS performers reveals a clear trend: smart money is flowing into digital disruption stories, speciality chemicals, healthcare infrastructure, and industrial champions. With 42 distinct stock ideas ranging from established pharma giants to fintech unicorns, these fund managers are positioning for India's next growth phase while maintaining selective exposure across market caps and sectors.: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Time of India
2 days ago
- Business
- Time of India
From Paytm to Eternal: 42 stocks where India's top performing PMS fund managers are betting on
India's sharpest money managers are placing bold bets on the market's most exciting new-age darlings and forgotten gems. The country's top 10 performing Portfolio Management Services (PMS) scheme in July made concentrated plays on everything from fintech unicorns to healthcare disruptors and speciality chemicals, shows data from PMS Bazaar. Here's where the smart money is flowing. InCred Asset Management - Healthcare Portfolio: Leading the Pack with 11.96% Returns The month's standout performer, InCred's Healthcare Portfolio, is doubling down on India's medical revolution with a 19.81% allocation to Healthcare Global Enterprises, the country's largest cancer care network. The fund's conviction play extends to diagnostics powerhouse Thyrocare Technologies (17.35%) and emerging player Krsnaa Diagnostics (11.62%). The healthcare-focused strategy also holds Jubilant Pharmova (10.04%) and RPG Life Sciences (6.81%), positioning itself to capitalise on India's growing healthcare infrastructure and rising medical tourism. Also Read | 7 multibagger stocks that FIIs are hoarding in 2025. Are you missing out? Valcreate's Digital Disruption Strategy: Betting Big on Fintech Giants Valcreate Investment Managers' IME Digital Disruption fund (up 6.34%) is making audacious bets on India's digital economy transformation. The fund has loaded up 22% in Eternal, followed by massive positions in fintech heavyweight One 97 Communications - Paytm (19.30%) and insurance aggregator PB Fintech (19.20%). The digital thesis extends to FSN E-Commerce Ventures - Nykaa (11.40%) and food delivery giant Swiggy (7.10%), capturing the entire new-age commerce ecosystem that's reshaping Indian consumer behaviour. Valcreate's Lifesciences Portfolio: Riding the Agrochemicals Wave Another Valcreate strategy making waves is their Lifesciences and Specialty Opportunities fund (8.48% returns), which has positioned itself as the go-to agrochemicals play. Leading the charge is Sharda Cropchem , with a commanding 15.85% weight, backed by pharma giant Divi's Laboratories (9.33%). The fund's agrochemical conviction deepens with Sumitomo Chemical India (8.08%), Dhanuka Agritech (7.49%), and Rallis India (7.31%), betting on India's agricultural modernisation and crop protection needs. Green Portfolio's MNC Advantage: Industrial Excellence Focus Green Portfolio's MNC Advantage fund (6.89% returns) is zeroing in on India's industrial backbone through multinational subsidiaries. KSB leads the portfolio at 12.68%, followed by engineering specialist Integra Engineering India (10.21%) and auto components player Federal-Mogul Goetze (9.42%). The strategy includes John Cockerill India (6.16%) and premium engineering brand Bosch (5.56%), capitalising on India's manufacturing renaissance and infrastructure buildout. Emkay's Pearls Strategy: Diversified Mid-Cap Play Emkay Investment Managers' Pearls fund (4.20% returns) mirrors the digital disruption theme with Eternal as its top holding (16.30%), while maintaining pharmaceutical exposure through Divi's Laboratories (9.70%). The fund balances growth with stability through Nesco (8.80%), Federal Bank (7.10%), and auto ancillary Sundram Fasteners (7.10%). Ambit's Micro Marvels: Small-Cap Specialisation Ambit Investment Advisors' Micro Marvels Portfolio (4.27% returns) is hunting for tomorrow's champions in India's small-cap universe. The fund spreads its bets across Rajratan Global Wire (7.00%), staffing services leader Teamlease Services (6.50%), and industrial plays Menon Bearings, Entero Healthcare Solutions, and Thejo Engineering (6.00% each). Wryght Research Factor Fund: Contrarian Fintech Bet The Factor Fund from Wryght Research (2.69% returns) demonstrates conviction in fintech recovery with One 97 Communications as its largest holding (7.73%). The fund diversifies across Hitachi Energy India (5.68%), Maharashtra Scooters (5.38%), fertiliser player Paradeep Phosphates (5.19%), and financial conglomerate Bajaj Holdings & Investment (4.91%). Valcreate's Growing India: Chemical Sector Concentration The Growing India fund (2.84% returns) maintains Valcreate's chemical sector thesis with Divi's Laboratories leading at 7.65%, supported by Sharda Cropchem (7.48%) and Rallis India (6.54%). The fund also holds Swaraj Engines (6.32%) and Sumitomo Chemical India (5.82%). Shade Capital Value Fund: Value Hunting Across Caps Shade Capital's Value Fund (2.87% returns) is pursuing deep value opportunities across industrial names like Kilburn Engineering (4.33%), TD Power Systems (4.15%), and wealth manager Nuvama Wealth Management (3.94%). The fund also holds infrastructure play Transrail Lighting (3.71%) and building materials company Interarch Building Products (3.36%). Brightseeds Xylem Maverick: Cash-Heavy Cautious Approach The most conservative among the top performers, Brightseeds' Xylem Maverick Strategy (2.55% returns) holds a massive 47.29% in Zerodha Nifty 1D Rate Liquid ETF & Cash, suggesting a defensive stance. When invested, the fund focuses on agrochemicals through Dharmaj Crop Guard (8.56%), Sudarshan Chemical Industries (7.00%), renewable energy via Borosil Renewables (6.37%), and steel tubes specialist Scoda Tubes (5.49%). Also Read | Share prices rise after you sell? Data from 967 retail-sold stocks confirms your worst fear The positioning of India's top PMS performers reveals a clear trend: smart money is flowing into digital disruption stories, speciality chemicals, healthcare infrastructure, and industrial champions. With 42 distinct stock ideas ranging from established pharma giants to fintech unicorns, these fund managers are positioning for India's next growth phase while maintaining selective exposure across market caps and sectors. ( Disclaimer : Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Economic Times
4 days ago
- Business
- Economic Times
PMS Tracker: Top 15 funds advance up to 14% in July; Maxiom, Kotak among biggest losers
Bottom performers: Maxiom, Kotak, Trivantage lead declines Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel At least 15 PMS funds across thematic, smallcap, and multicap strategies delivered gains in July 2025, with InCred Asset Management's Focused Healthcare Portfolio emerging as the top performer, posting a 14.29% monthly return, according to data from PMS Healthcare Portfolio followed with an 11.96% gain, while Valcreate Investment Managers' Lifesciences and Specialty Opportunities strategy rose 8.48% during the month. Green Portfolio's MNC Advantage added 6.89%, and Valcreate's IME Digital Disruption gained 6.34% in notable performers included Wallfort PMS and Advisory Services' Diversified Fund, which gained 4.88% in July 2025, Maximal Capital's Income Fund, up 4.55%, and Ambit Investment Advisors' Micro Marvels Portfolio, which rose 4.27%. Emkay Investment Managers' Pearls strategy climbed 4.20%, and Qode Advisors' Future Horizon added 2.91% during the multicap and flexicap strategies, ithought Financial's VRDDHI and Shade Capital's Value Fund each gained 2.87%, Valcreate's Growing India strategy rose 2.84%, Wryght Research's Factor Fund advanced 2.69%, White Whale Partners' North Star Portfolio was up 2.64%, and Brightseeds Advisors' Xylem Maverick Strategy closed the month 2.55% the losing side, Maxiom Asset Management's PMS – EMERALD strategy fell 9.54% in July, the steepest decline among tracked portfolios. Kotak Mahindra AMC's Fintech strategy dropped 9.19% during the month, while Trivantage Capital's Small and Midcap Financials slid 7.41%.Moat Financial Services' UpperCrust Wealth Fund declined 7.09%, ASK Investment Managers' Financial Opportunities Portfolio lost 7.06%, and Shree Rama Managers' Vriddhi Plan fell 6.75%. ASK's Emerging Opportunities Portfolio was down 6.73%, and Capitalmind's Adaptive Momentum dropped 6.31%.Other laggards included Tulsian PMS, which fell 6.19%, Right Horizons' Alphabots Midcap 29, down 6.09%, Bonanza Portfolio's Growth, which dropped 5.98%, Aditya Birla Sun Life AMC 's India Special Opportunities Portfolio, lower by 5.95%, Wallfort PMS's Focus Fund, which slipped 5.85%, Atlas Integrated Finance's Debt Equity Hybrid PMS Fund, down 5.82%, Bonanza Portfolio's Edge and Value strategies, which lost 5.78% and 5.76% respectively, Alchemy Capital's Smart Alpha 250, lower by 5.67%, Marcellus Investment Managers' Consistent Compounders, which declined 5.61%, Trivantage Capital's Edge Portfolio, down 5.46%, and 2Point2 Capital's Long Term Value Fund, which ended the month 5.40% July saw strong gains in healthcare-focused and select thematic strategies, while several multicap, sectoral, and small-and-midcap portfolios faced steep losses, underscoring continued divergence in PMS performance.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Time of India
4 days ago
- Business
- Time of India
PMS Tracker: Top 15 funds advance up to 14% in July; Maxiom, Kotak among biggest losers
At least 15 PMS funds across thematic, smallcap, and multicap strategies delivered gains in July 2025, with InCred Asset Management's Focused Healthcare Portfolio emerging as the top performer, posting a 14.29% monthly return, according to data from PMS Bazaar. InCred's Healthcare Portfolio followed with an 11.96% gain, while Valcreate Investment Managers' Lifesciences and Specialty Opportunities strategy rose 8.48% during the month. Green Portfolio's MNC Advantage added 6.89%, and Valcreate's IME Digital Disruption gained 6.34% in July. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Other notable performers included Wallfort PMS and Advisory Services' Diversified Fund, which gained 4.88% in July 2025, Maximal Capital's Income Fund, up 4.55%, and Ambit Investment Advisors' Micro Marvels Portfolio, which rose 4.27%. Emkay Investment Managers' Pearls strategy climbed 4.20%, and Qode Advisors' Future Horizon added 2.91% during the month. Among multicap and flexicap strategies, ithought Financial's VRDDHI and Shade Capital's Value Fund each gained 2.87%, Valcreate's Growing India strategy rose 2.84%, Wryght Research's Factor Fund advanced 2.69%, White Whale Partners' North Star Portfolio was up 2.64%, and Brightseeds Advisors' Xylem Maverick Strategy closed the month 2.55% higher. Bottom performers: Maxiom, Kotak, Trivantage lead declines On the losing side, Maxiom Asset Management's PMS – EMERALD strategy fell 9.54% in July, the steepest decline among tracked portfolios. Kotak Mahindra AMC's Fintech strategy dropped 9.19% during the month, while Trivantage Capital's Small and Midcap Financials slid 7.41%. Live Events Moat Financial Services' UpperCrust Wealth Fund declined 7.09%, ASK Investment Managers' Financial Opportunities Portfolio lost 7.06%, and Shree Rama Managers' Vriddhi Plan fell 6.75%. ASK's Emerging Opportunities Portfolio was down 6.73%, and Capitalmind's Adaptive Momentum dropped 6.31%. Other laggards included Tulsian PMS, which fell 6.19%, Right Horizons' Alphabots Midcap 29, down 6.09%, Bonanza Portfolio's Growth, which dropped 5.98%, Aditya Birla Sun Life AMC 's India Special Opportunities Portfolio, lower by 5.95%, Wallfort PMS's Focus Fund, which slipped 5.85%, Atlas Integrated Finance's Debt Equity Hybrid PMS Fund, down 5.82%, Bonanza Portfolio's Edge and Value strategies, which lost 5.78% and 5.76% respectively, Alchemy Capital's Smart Alpha 250, lower by 5.67%, Marcellus Investment Managers' Consistent Compounders, which declined 5.61%, Trivantage Capital's Edge Portfolio, down 5.46%, and 2Point2 Capital's Long Term Value Fund, which ended the month 5.40% lower. Overall, July saw strong gains in healthcare-focused and select thematic strategies, while several multicap, sectoral, and small-and-midcap portfolios faced steep losses, underscoring continued divergence in PMS performance. Also read | Sebi looks to further ease regulations for foreign investors
